With a market cap of $10.6 billion, Baxter International Inc. (BAX) is a global healthcare company that develops and delivers a broad portfolio of medical products, therapies, healthcare technologies, and pharmaceutical solutions. The company serves hospitals, clinics, dialysis centers, nursing homes, ambulatory surgery centers, and home-care patients through its three business segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Companies worth more than $10 billion are generally labeled as “large-cap” stocks and Baxter International fits this criterion perfectly. It operates across multiple international markets, including North America, Europe, Asia, Latin America, the Middle East, Africa, Australia, and New Zealand.